Full-Time

Senior Manager

Program, IT PMO

Deadline 3/4/27
Sysmex

Sysmex

1,001-5,000 employees

Manufactures automated hematology analyzers and diagnostics

Compensation Overview

$141.4k - $222.2k/yr

+ Annual Incentive Bonus

Vernon Hills, IL, USA

In Person

Category
Business & Strategy (1)
Required Skills
Forecasting
Word/Pages/Docs
JIRA
Risk Management
Confluence
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree (specialization in IT preferred) or 15 years project management experience required, including experience in the Armed Forces, with minimum 5 years of progressive experience in project and program management, including oversight of multiple concurrent initiatives.
  • PMI PMP certification required or equivalent.
  • Experience directly managing Project Managers or equivalent delivery leads required.
  • Strong written and oral communication skills required. Must be comfortable communicating with all levels of the organization.
  • Advanced proficiency in Microsoft Office (PowerPoint, Excel, Word), including executive-level presentations, financial and schedule analysis, and structured documentation.
  • Hands-on experience with enterprise project and portfolio management tools (e.g. Smartsheet, Jira, Confluence, Planview, or equivalent).
  • Highly visible position to the external customer requiring extensive interpersonal contact. Professional conduct necessary at all times even under stressful conditions. Strong presentation and persuasive skills necessary.
  • Must be highly organized with proven track record of follow up, successful execution, and effective at driving results. Must demonstrate ability to resolve conflict and adapt to change. Proven record of delivering projects on target, on time and on budget.
Responsibilities
  • Oversee a few small size programs or multiple medium-to-large size projects and/or portfolio initiatives from initial concept through final implementation, including new application development as well as enhancements and upgrades to existing platforms.
  • Manage, coach, and develop Project Managers as direct reports, ensuring consistent planning, execution, accountability, performance, and escalation management across interdependent and independent initiatives.
  • Ensure development, integration, and execution of project work plans, schedules, estimates, resource plans, and status reporting across programs, projects, and portfolio initiatives.
  • Manage and maintain program, project, and portfolio governance, roadmaps, operating cadence, and executive-level reporting in alignment with established organizational processes, consulting with management on any material changes.
  • Consult with management to review, prioritize, and approve project proposals; define goals, timelines, funding constraints, staffing requirements, and delivery approach across the applications portfolio.
  • Lead program- and portfolio-level risk, issue, and dependency management, driving analysis, mitigation strategies, and timely escalation of systemic or cross-project impacts.
  • Accountable for program and portfolio financial management, including budgeting, forecasting, cost tracking, and variance management across all assigned initiatives.
  • Drive adoption of best practices, standardization, and continuous improvement across the project management function to improve delivery efficiency, consistency, and quality of reporting.
  • Proactively manage cross-project resource planning and capacity, resolving conflicts to support delivery commitments, minimize disruption to operations, and protect business and customer outcomes.
  • Define success criteria, expected benefits, and measurable outcomes for programs and portfolio initiatives, and support post-implementation adoption and value realization.
  • Perform other duties as assigned, consistent with the scope and accountability of the role.
Desired Qualifications
  • 6-8 years of Medical Diagnostics industry experience preferred but not required.

Sysmex designs and sells instruments and reagents for in-vitro diagnostics, with a focus on automated hematology analyzers that count and evaluate blood cells, enabling clinical decision-making. Over time, it expanded into genetics through the acquisition of Oxford Gene Technology and into rapid antimicrobial testing with Astrego, broadening its diagnostic portfolio. The company differentiates itself by growing through acquisitions to build a diverse, global product line and by maintaining a strong brand presence in workflows for hematology, genetics, and infectious disease testing across more than 190 countries. Its goal is to provide essential, reliable diagnostic tools that support healthcare worldwide, helping clinicians diagnose and treat diseases faster and more accurately.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Kobe, Japan

Founded

1968

Simplify Jobs

Simplify's Take

What believers are saying

  • CN-9000 launched April 2026 processes 1,000 samples/hour in North America.
  • Dan Zortman appointed CEO July 2024 drives commercial growth from Roche.
  • RIKEN GENESIS became subsidiary in 2026 strengthening genomics capabilities.

What critics are saying

  • Roche Cobas t 766 erodes hemostasis share with 1,200 tests/hour throughput.
  • Abbott Alinity undercuts XQ-320 in physician labs via pricing in 6-12 months.
  • FDA delays hinotori robot approval blocks entry against da Vinci in 6-12 months.

What makes Sysmex unique

  • Sysmex pioneered Japan's first automated hematology analyzer in 1963.
  • Sysmex brand launched in 1978 for automated hematology analyzers.
  • Sysmex expanded into genomics via 2017 Oxford Gene Technology acquisition.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Sysmex who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Parental Leave

Bereavement Leave

401(k) Retirement Plan

401(k) Company Match

Annual Incentive Bonus

Company News

Sysmex Corporation
Mar 5th, 2026
Sysmex Acquires Additional Shares in RIKEN GENESIS and Converts Company to a Subsidiary

This section provides Sysmex’s most recent news releases related to IR information, products and support, research and development, corporate information and other notifications.

Sysmex Corporation
Jan 22nd, 2026
Launch of "CN(TM)-9000 Automated Hemostasis Solution" for Large-Scale Laboratories in North America - Supporting the Optimization of Laboratory Workflow - (Sysmex America)

Launch of "CN(TM)-9000 Automated Hemostasis Solution" for large-scale laboratories in North America - supporting the optimization of laboratory workflow - (Sysmex America). Sysmex America, Inc., a Sysmex Group company, has launched the "CN(TM)-9000 Automated Hemostasis Solution" as a new addition to the CN-Series for hemostasis testing in the North American market. This product supports further automation and increased efficiency in testing operations at large hospitals and testing centers with high test volumes. In addition to standalone operation, the CN(TM)-9000 is compatible with Total Laboratory Automation (TLA) lines, enabling flexible system configurations tailored to the size and operational needs of each laboratory. For further details, please refer to Sysmex America's press release. Going forward, Sysmex will continue to work to further enhance the value of hemostasis through product development and services that address the increasingly varied and sophisticated needs of medical settings, thereby contributing to improved patient outcomes. * The purpose of this news is to communicate its business activities to its stakeholders. It may or may not include information about Sysmex's products or their research and development, but this is not intended for promotion, advertising, or medical advice. The information contained in this press release is current as of the date of the announcement but may be subject to change without prior notice.

LabX Media Group
Jan 21st, 2026
Sysmex America Launches CN-9000 to Streamline Hemostasis Workflow in Busy Clinical Labs

Sysmex America launches CN-9000 to streamline hemostasis workflow in busy clinical labs. Designed for high-throughput labs, the CN-9000 boosts efficiency, reduces manual handling, and integrates seamlessly with lab automation systems. Listen with Speechify Sysmex America, Inc., a leader in diagnostic solutions, has announced the launch of the CN-9000 Automated Hemostasis Solution, the latest innovation in its CN-Series. This new system is engineered to help clinical laboratories of all sizes - especially high-volume ones - optimize workflow and keep up with increasing testing demands. With the ability to process up to 1,000 samples per hour, the CN-9000 supports continuous sample loading, automated rerun/reflex testing, and seamless connectivity to compatible total laboratory automation (TLA) lines. Features like closed-tube sampling and Preanalytical Sample Integrity (PSI(TM) checks enhance safety while reducing errors and manual labor. Key features of the CN-9000. * High-throughput processing: up to 1,000 samples/hour * Automated rerun/reflex testing * Closed-tube sampling and PSI(TM) checks * Modular setup with support for CN-3000/CN-6000 analyzers * Optional integration with Sysmex TS-10(TM) Tube Sorter and Archiver * Flexible layout with turn modules for space-saving configurations "Sysmex America's hemostasis solutions help labs keep up with growing testing demands," said Dan Zortman, CEO of Sysmex America. "With the CN-Series, CN-9000, we're giving labs a reliable, high-throughput, walkaway solution that makes daily operations easier and more efficient." Supporting smarter, scalable lab operations. The CN-9000's modular design allows for integration of up to three analyzers and multiple accessories, making it highly adaptable for both current and future lab needs. With intelligent tube routing and minimized manual intervention, the CN-9000 supports lab managers in achieving consistent, scalable, and efficient testing operations. For more information about the CN-9000 and Sysmex America's full hemostasis product line, visit www.sysmex.com. * craig bradley craig bradley bsc (hons), msc, has a strong academic background in human biology, cardiovascular sciences, and biomedical engineering. Since 2025, he has been working with labx media group as a SEO editor. Craig can be reached at [email protected]. View full profile.

Sysmex Corporation
Jan 19th, 2026
Sysmex Makes Megakaryon Corporation into a Subsidiary, Aiming at Accelerating Efforts in the Field of Regenerative and Cellular Medicine

Sysmex Corporation’s corporate philosophy defines its mission as “Shaping the advancement of healthcare.” On that basis, we provide diagnostic instruments, reagents and software throughout the world.

Sysmex Corporation
Aug 27th, 2025
Sysmex America Recognized with Brandon Hall Group Bronze Award for Leadership Development

Chicago - August 27, 2025 - Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, has been recognized with a Brandon Hall Group(TM) Bronze award for excellence in the Best Development Program for Frontline Leaders category for the Considering the Shift Program offered through Sysmex University.